Infectious Diseases

ABC-Sepsis

Study

ACORN

Study

ACT HIV

Study

ACTIV-3-TICO

Study

ACTIV-4A (P2Y12 inhibitor plus heparin)

Study

ACTIV-4a (SGLT2 inhibitors)

Study

ACTIV-4C

Study

ACTIV-6 (fluvoxamine)

Study

ACTIV-6 (ivermectin)

Study

ACTIV-6 (montelukast)

Study

ACTT-1

Study

ACTT-4

Study

Acute bacterial meningitis

Disease

Acute bacterial prostatitis

Disease

Acute bacterial rhinosinusitis

Disease

Acute bronchitis

Disease

Acute bronchitis — Diagnosis and management

Pathway

Acute diarrhea

Disease

Acute epididymitis

Disease

Acute otitis externa

Disease

Acute otitis media

Disease

Acute pyelonephritis

Disease

Acute watery diarrhea

Finding

Acyclovir

Drug

ADAPT-PO

Study

ADAPT-Sepsis (CRP-guided)

Study

ADAPT-Sepsis (procalcitonin-guided)

Study

Adjunctive Milrinone for Septic Shock

Study

ADRENAL

Study

AECOPD

Study

African trypanosomiasis

Disease

AIRFLO

Study

ALBIOS

Study

Allergic bronchopulmonary aspergillosis

Disease

ALLIUM

Study

Amantadine

Drug

AMBITION-CM

Study

AMIKINHAL

Study

Amoxicillin

Drug

Amoxicillin / clavulanate

Drug

Amoxicillin / clavulanate XR

Drug

ANCHOR

Study

ANDROMEDA-SHOCK

Study

Animal bites

Disease

Annane Trial

Study

ANRS 174 DOXYVAC (4CMenB vaccine)

Study

ANRS 174 DOXYVAC (doxycycline PEP)

Study

ANRS IPERGAY

Study

Antimicrobial-resistant Gram-negative infections

Disease

APROCCHSS

Study

APW-RSV-II

Study

ARBs CORONA II

Study

AReSVi-006

Study

ARISE

Study

Artemisinin Combination for Postpartum Malaria

Study

ASSIT

Study

Asymptomatic bacteriuria

Disease

ATESS

Study

ATLAS (cabotegravir and rilpivirine)

Study

ATLAS-2M (152-week results)

Study

ATLAS-2M (48-week results)

Study

ATTKPATRASCOVID19

Study

AURORA (maribavir)

Study

AVENIR (children)

Study

AVENIR (infants)

Study

Axillary lymphadenopathy

Finding

Azithromycin

Drug

AZT Trial

Study

Aztreonam

Drug

Aztreonam / avibactam

Drug